Examkin

Soru

Zorluk: Çok zorInfectious Diseases

A 34-year-old man with advanced, untreated HIV infection is evaluated in the emergency department for a two-week history of constant, severe headaches, low-grade fevers, and intermittent nausea. He appears lethargic. Vital signs show a temperature of 38.1°C (100.6°F), blood pressure of 118/76 mmHg, and a heart rate of 92/min. Neurologic examination shows mild nuchal rigidity but no focal deficits. Laboratory studies confirm a CD4 count of 18 cells/mm³. A lumbar puncture is performed, demonstrating an elevated opening pressure of 290 mm H2O. Cerebrospinal fluid (CSF) analysis reveals 45 leukocytes/mm³ (90% lymphocytes), a glucose level of 32 mg/dL, and a protein level of 88 mg/dL. A CSF India ink stain displays encapsulated budding yeast, and the cryptococcal antigen assay is profoundly positive.

Arrange the following therapeutic interventions in the most appropriate chronological order of their initiation for the optimal management of this patient.

  1. 1Administer intravenous liposomal amphotericin B and oral flucytosine.
  2. 2Administer oral fluconazole 400 mg daily.
  3. 3Initiate combination antiretroviral therapy (ART).
  4. 4Administer oral fluconazole 200 mg daily.

Cevap

The correct chronological sequence of initiation is: Induction with amphotericin B and flucytosine (Week 0), followed by consolidation with high-dose fluconazole (Week 2), followed by initiation of ART (Week 4-6), and finally maintenance with low-dose fluconazole (Week 10).
The management of HIV-associated cryptococcal meningitis follows a rigorous chronological protocol. First, an induction phase (weeks 0-2) utilizes fungicidal liposomal amphotericin B and flucytosine. Second, a consolidation phase (weeks 2-10) uses high-dose fluconazole (400 mg daily). Third, combination ART is uniquely delayed in cryptococcal meningitis to 4-6 weeks after antifungal initiation to prevent fatal CNS IRIS, placing its initiation appropriately within the consolidation phase. Finally, maintenance therapy with low-dose fluconazole (200 mg daily) begins at week 10 after consolidation is complete.

Adım Adım Çözüm

1
Diagnose the underlying condition.
The patient has HIV-associated cryptococcal meningitis.
The diagnosis is confirmed by the profoundly low CD4 count, symptoms of elevated intracranial pressure, and CSF findings positive for encapsulated budding yeast (India ink) and cryptococcal antigen.
2
Identify the first phase of pharmacologic treatment (Induction).
Initiate intravenous liposomal amphotericin B and oral flucytosine.
Induction therapy requires potent fungicidal agents for 2 weeks to rapidly sterilize the cerebrospinal fluid and reduce mortality.
3
Identify the second phase of treatment (Consolidation).
Transition to oral fluconazole 400 mg daily.
After 2 weeks of successful induction, therapy is stepped down to high-dose oral fluconazole for an 8-week consolidation phase to ensure the infection does not relapse.
4
Determine the optimal timing for starting antiretroviral therapy (ART).
Initiate combination ART.
Unlike most opportunistic infections, ART in cryptococcal meningitis must be delayed for 4 to 6 weeks after starting antifungal therapy to avoid fatal central nervous system immune reconstitution inflammatory syndrome (IRIS). Therefore, ART is started during the consolidation phase.
5
Identify the final ongoing phase of treatment (Maintenance).
Transition to oral fluconazole 200 mg daily.
After completing the 8-week consolidation phase (at week 10 overall), the patient is transitioned to lower-dose maintenance therapy to provide secondary prophylaxis until the immune system recovers.

Anahtar Kavram

The management of HIV-associated cryptococcal meningitis requires a strict, multi-phase antifungal regimen (induction, consolidation, maintenance) with carefully delayed initiation of antiretroviral therapy to prevent severe immune reconstitution inflammatory syndrome (IRIS).
Tahmini Süre:2m 0s
Bu soruyu puanla

Konular

Infectious Diseases

Bu konudan daha fazla soru